- GM-CSF and low-dose araC treatment of AML in prolonged hypoplasia with residual leukemic cells after induction chemotherapy
-
Min YH, Kim SE, Lee ST, Lee SJ, Hahn JS, Ko YW
- KMID: 1381222
- Yonsei Med J.
- 1994 Mar;35(1):91-96.
- doi: 10.3349/ymj.1994.35.1.91
We describe a case with acute myelogenous leukemia (AML; M2) who developed prolonged marrow hypoplasia with residual leukemic blasts and recurrent infections after induction chemotherapy. He was treated successfully with... -
- CITED
-
- Close
- SHARE
-
- Close
